Wash U Spinout PerianDX Raises $30M

In order to offer transparency into how our stories are produced and to teach our readers about the importance of media literacy online, EQ's editorial team provides a quick self-rating of the integrity of the articles and the facts presented against the following EQ IQ metrics.

  • Published on December 6, 2021
  • In Syndication

St. Louis-based PierianDx has been able to raise $30 million in financing. Launched in 2014, PierianDx was spun out of Washington University.

PierianDx's software and services provide clinical genomic analysis for treatment of complex diseases.

New York-based health care investment firm OrbiMed, Health Catalyst Capital, Research Triangle Institute, Inova Health System, ATW Partners and SJF Ventures have invested in PierianDx.

Check out the full story by Nathan Rubbelke on STL Inno.

Enjoy our work? Follow us on social media!